Kymera Therapeutics, Inc. (KYMR)
85.40
+0.47
(+0.55%)
USD |
NASDAQ |
Apr 02, 16:00
85.34
-0.06
(-0.07%)
After-Hours: 20:00
Kymera Therapeutics Price : 85.40 for April 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Revolution Medicines, Inc. | 99.12 |
| Gilead Sciences, Inc. | 139.71 |
| Regeneron Pharmaceuticals, Inc. | 761.85 |
| Structure Therapeutics, Inc. | 53.48 |
| ACADIA Pharmaceuticals, Inc. | 22.20 |
Price Related Metrics
| PS Ratio | 183.94 |
| PEG Ratio | -0.967 |
| Price to Book Value | 4.414 |
| Earnings Yield | -4.31% |
| Market Cap | 7.006B |
| PEGY Ratio | -0.967 |